M. E. Safar
Impact in
-
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Cardiovascular Function and Risk Factors
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Blood Pressure and Hypertension Studies 23
- Cardiovascular Health and Disease Prevention 22
- Heart Rate Variability and Autonomic Control 10
-
- Eicosanoids and Hypertension Pharmacology 4
- Co-authors
- Gérard M. LondonDaniel R. KaiserC GiannattasioMirian Starmans‐KoolC. ThuillezLuc M. Van BortelJ.R. CockcroftDaniel Duprez
- Journals
- Journal of Cardiovascular Pharmacology (8 papers)American Journal of Hypertension (7 papers)Journal of Hypertension (6 papers)Current Pharmaceutical Design (2 papers)Clinical Science (2 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
M. E. Safar
59 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 111
- Cardiology and Cardiovascular Medicine 1.5k
- Molecular Medicine 163
- Applied Microbiology and Biotechnology 48
- Critical Care and Intensive Care Medicine 103
- Endocrinology 72
Countries citing papers authored by M. E. Safar
This map shows the geographic impact of M. E. Safar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Safar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Safar more than expected).
Fields of papers citing papers by M. E. Safar
This network shows the impact of papers produced by M. E. Safar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Safar. The network helps show where M. E. Safar may publish in the future.
Co-authors
The 25 scholars most cited alongside M. E. Safar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 22 | |
| 2 | 2009 | 32 | |
| 3 | 2009 | 31 | |
| 4 | 2008 | 1 | |
| 5 | 2002 | 52 | |
| 6 | 2002 | 483 | |
| 7 | 2000 | 132 | |
| 8 | 1998 | 9 | |
| 9 | 1998 | 201 | |
| 10 | 1998 | 13 | |
| 11 | 1997 | 9 | |
| 12 | 1997 | 21 | |
| 13 | 1995 | 3 | |
| 14 | 1992 | 19 | |
| 15 | 1992 | 2 | |
| 16 | Split intrarenal hemodynamics in renovascular hypertension. | 1991 | 12 |
| 17 | 1991 | 3 | |
| 18 | 1990 | 22 | |
| 19 | 1990 | 5 | |
| 20 | 1988 | 1 |
About M. E. Safar
M. E. Safar is a scholar working on Cardiology and Cardiovascular Medicine, Biochemistry, Nephrology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 63 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (23 papers), Cardiovascular Health and Disease Prevention (22 papers), Heart Rate Variability and Autonomic Control (10 papers), Nitric Oxide and Endothelin Effects (6 papers), Hormonal Regulation and Hypertension (5 papers), Sodium Intake and Health (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.5k citations), Molecular Medicine (163 citations), Applied Microbiology and Biotechnology (48 citations), Critical Care and Intensive Care Medicine (103 citations) and Endocrinology (72 citations). M. E. Safar has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Gérard M. London, Daniel R. Kaiser, C Giannattasio, Mirian Starmans‐Kool, C. Thuillez, Luc M. Van Bortel, J.R. Cockcroft, Daniel Duprez, Sylvain J. Marchais and Alain P. Guérin. Their work appears in journals such as Journal of Cardiovascular Pharmacology, American Journal of Hypertension, Journal of Hypertension, Current Pharmaceutical Design and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.